# FAPO-2: Cardiac Patient Monitoring Tool for Clinical Observation and Arrhythmia Detection

Study · id `cardio:ct-nct07174206` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07174206](<https://clinicaltrials.gov/study/NCT07174206>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07174206

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 520 participants.

## Technical summary

Registry record NCT07174206. Non-randomized; single masking; primary purpose health services research. Start 2025-02-07 (actual); primary completion 2026-01-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; single masking; primary purpose health services research
- Phase: Not applicable
- Enrolled: 520 participants (planned count; ClinicalTrials.gov record NCT07174206, source copy `cardio:ctgov-nct07174206-2025-09-15`, retrieved 2026-10-26)
- Started: 2025-02-07 (actual) (ClinicalTrials.gov record NCT07174206, source copy `cardio:ctgov-nct07174206-2025-09-15`, retrieved 2026-10-26)
- Primary completion: 2026-01-31 (anticipated) (ClinicalTrials.gov record NCT07174206, source copy `cardio:ctgov-nct07174206-2025-09-15`, retrieved 2026-10-26)
- Completion: 2026-02-28 (anticipated) (ClinicalTrials.gov record NCT07174206, source copy `cardio:ctgov-nct07174206-2025-09-15`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT07174206, source copy `cardio:ctgov-nct07174206-2025-09-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07174206-2025-09-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: FAPO-2: Cardiac Patient Monitoring Tool for Clinical Observation and Arrhythmia Detection
- Acronym: FAPO-2
- Condition: Heart Diseases
- Condition: Atrial Fibrillation (AF)
- Condition: Angina, Unstable
- Intervention (Device): Smartwatch - all data
- Intervention (Device): Portable holter system
- Intervention (Procedure): Telemonitoring
- Intervention (Other): AI Model Development
- Intervention (Device): Smartwatch - ECG and HR
- Lead sponsor: University of Sao Paulo
- Lead sponsor class: OTHER
- Collaborator: Samsung Eletrônica da Amazônia LTDA
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)
- Registry lists this organization as the lead sponsor: University of Sao Paulo (`cardio:org-university-of-sao-paulo`)

## Provenance

Content hash: 466e6a24b8255a03de86056571f92fb6acb3fd69d639f65cc8d5b7e4bb3d8b18
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
